New monoclonal antibody vaccine slashes malaria risk in children
In a recent study published in The New England Journal of Medicine, researchers evaluated the safety and efficacy of a novel monoclonal antibody-based vaccine (L9LS) in children aged 6 to 10. The study establishes the lack of safety concerns associated …